Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.39
MCK's Cash to Debt is ranked lower than
65% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.66 vs. MCK: 0.39 )
Ranked among companies with meaningful Cash to Debt only.
MCK' s Cash to Debt Range Over the Past 10 Years
Min: 0.05  Med: 0.52 Max: 3.01
Current: 0.39
0.05
3.01
Equity to Asset 0.16
MCK's Equity to Asset is ranked lower than
91% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. MCK: 0.16 )
Ranked among companies with meaningful Equity to Asset only.
MCK' s Equity to Asset Range Over the Past 10 Years
Min: 0.15  Med: 0.26 Max: 0.35
Current: 0.16
0.15
0.35
Interest Coverage 9.82
MCK's Interest Coverage is ranked higher than
58% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.25 vs. MCK: 9.82 )
Ranked among companies with meaningful Interest Coverage only.
MCK' s Interest Coverage Range Over the Past 10 Years
Min: 7.94  Med: 9.13 Max: 12.77
Current: 9.82
7.94
12.77
F-Score: 5
Z-Score: 4.43
M-Score: -2.45
WACC vs ROIC
8.01%
18.57%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 1.85
MCK's Operating margin (%) is ranked lower than
74% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.25 vs. MCK: 1.85 )
Ranked among companies with meaningful Operating margin (%) only.
MCK' s Operating margin (%) Range Over the Past 10 Years
Min: 1.12  Med: 1.64 Max: 1.9
Current: 1.85
1.12
1.9
Net-margin (%) 1.04
MCK's Net-margin (%) is ranked lower than
72% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.50 vs. MCK: 1.04 )
Ranked among companies with meaningful Net-margin (%) only.
MCK' s Net-margin (%) Range Over the Past 10 Years
Min: 0.77  Med: 0.98 Max: 1.16
Current: 1.04
0.77
1.16
ROE (%) 22.46
MCK's ROE (%) is ranked higher than
91% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.00 vs. MCK: 22.46 )
Ranked among companies with meaningful ROE (%) only.
MCK' s ROE (%) Range Over the Past 10 Years
Min: 13.37  Med: 16.25 Max: 19.97
Current: 22.46
13.37
19.97
ROA (%) 3.55
MCK's ROA (%) is ranked higher than
53% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.50 vs. MCK: 3.55 )
Ranked among companies with meaningful ROA (%) only.
MCK' s ROA (%) Range Over the Past 10 Years
Min: 2.79  Med: 4.01 Max: 4.73
Current: 3.55
2.79
4.73
ROC (Joel Greenblatt) (%) 135.92
MCK's ROC (Joel Greenblatt) (%) is ranked higher than
96% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.89 vs. MCK: 135.92 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MCK' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 56.83  Med: 115.89 Max: 183.42
Current: 135.92
56.83
183.42
Revenue Growth (3Y)(%) 15.90
MCK's Revenue Growth (3Y)(%) is ranked higher than
84% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.60 vs. MCK: 15.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MCK' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -7.8  Med: 11.60 Max: 26.5
Current: 15.9
-7.8
26.5
EBITDA Growth (3Y)(%) 16.70
MCK's EBITDA Growth (3Y)(%) is ranked higher than
77% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.30 vs. MCK: 16.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MCK' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -52.7  Med: 11.90 Max: 171.6
Current: 16.7
-52.7
171.6
EPS Growth (3Y)(%) 10.50
MCK's EPS Growth (3Y)(%) is ranked higher than
52% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.50 vs. MCK: 10.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MCK' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -44.5  Med: 12.30 Max: 87.1
Current: 10.5
-44.5
87.1
» MCK's 10-Y Financials

Financials (Next Earnings Date: 2016-05-04)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2015

MCK Guru Trades in Q2 2015

Jim Simons 546,400 sh (New)
Andreas Halvorsen 625,568 sh (New)
Joel Greenblatt 229,882 sh (+13406.58%)
Paul Tudor Jones 6,881 sh (+32.86%)
Pioneer Investments 476,784 sh (+2.02%)
Vanguard Health Care Fund 6,342,800 sh (unchged)
Steven Cohen Sold Out
Lee Ainslie Sold Out
Daniel Loeb Sold Out
Mario Gabelli 17,300 sh (-1.06%)
Scott Black 38,358 sh (-1.08%)
Leon Cooperman 691,603 sh (-1.09%)
Larry Robbins 1,025,749 sh (-17.54%)
Ray Dalio 29,713 sh (-44.27%)
» More
Q3 2015

MCK Guru Trades in Q3 2015

Steven Cohen 4,700 sh (New)
Ken Fisher 6,433 sh (New)
First Pacific Advisors 47,405 sh (New)
Andreas Halvorsen 2,274,228 sh (+263.55%)
Larry Robbins 1,810,249 sh (+76.48%)
Joel Greenblatt 280,458 sh (+22.00%)
Paul Tudor Jones 8,278 sh (+20.30%)
Mario Gabelli 17,700 sh (+2.31%)
Vanguard Health Care Fund 6,471,080 sh (+2.02%)
Pioneer Investments 485,930 sh (+1.92%)
Leon Cooperman Sold Out
Scott Black 38,293 sh (-0.17%)
Jim Simons 535,500 sh (-1.99%)
Ray Dalio 26,713 sh (-10.10%)
» More
Q4 2015

MCK Guru Trades in Q4 2015

Manning & Napier Advisors, Inc 28,820 sh (New)
Jerome Dodson 80,000 sh (New)
George Soros 2,100 sh (New)
John Paulson 8,100 sh (New)
Ray Dalio 41,813 sh (+56.53%)
Andreas Halvorsen 2,761,995 sh (+21.45%)
Larry Robbins 2,192,841 sh (+21.13%)
Vanguard Health Care Fund 6,619,780 sh (+2.30%)
Jim Simons Sold Out
Steven Cohen Sold Out
Ken Fisher Sold Out
First Pacific Advisors 43,865 sh (-7.47%)
Mario Gabelli 13,925 sh (-21.33%)
Pioneer Investments 237,417 sh (-51.14%)
Scott Black 9,446 sh (-75.33%)
Paul Tudor Jones 2,028 sh (-75.50%)
Joel Greenblatt 46,915 sh (-83.27%)
» More
Q1 2016

MCK Guru Trades in Q1 2016

Arnold Van Den Berg 70,171 sh (New)
Manning & Napier Advisors, Inc 42,880 sh (+48.79%)
Vanguard Health Care Fund 7,165,280 sh (+8.24%)
Jerome Dodson 80,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with MCK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on McKesson Corp

Wallace Weitz Comments on McKesson - Apr 22, 2016

McKesson (NYSE:MCK) distributes drugs, equipment, and health and beauty products throughout North America and portions of Europe. The company also delivers software solutions and outsourced services to hospitals, pharmacies and other healthcare organizations. Merger-related customer losses (McKesson accounts Omnicare, Target Pharmacy and Rite Aid are moving to competing wholesalers after being acquired), the return of generic drug deflation and concerns of lower future branded drug inflation combined to drive McKesson’s stock down nearly 40% from its high last summer. Having done detailed work on the company roughly nine years prior, we sharpened our pencils again late last year and initiated a position at $150 in January. The drug wholesaling business is an attractive oligopoly characterized by intense but rational competition, stable growth, healthy returns on capital and consistent excess cash generation. While McKesson’s business faces some near-term headwinds, we believe it is an attractive investment over the long term.

From Wallace Weitz (Trades, Portfolio)'s Weitz Value Fund 1st quarter 2016 commentary.

Check out Wallace Weitz latest stock trades

Top Ranked Articles about McKesson Corp

Wallace Weitz Comments on McKesson Guru stock highlight
McKesson (NYSE:MCK) distributes drugs, equipment, and health and beauty products throughout North America and portions of Europe. The company also delivers software solutions and outsourced services to hospitals, pharmacies and other healthcare organizations. Merger-related customer losses (McKesson accounts Omnicare, Target Pharmacy and Rite Aid are moving to competing wholesalers after being acquired), the return of generic drug deflation and concerns of lower future branded drug inflation combined to drive McKesson’s stock down nearly 40% from its high last summer. Having done detailed work on the company roughly nine years prior, we sharpened our pencils again late last year and initiated a position at $150 in January. The drug wholesaling business is an attractive oligopoly characterized by intense but rational competition, stable growth, healthy returns on capital and consistent excess cash generation. While McKesson’s business faces some near-term headwinds, we believe it is an attractive investment over the long term. Read more...
McKesson Officer Sells 101,835 Shares of Company Company announced in September plans to acquire pharmaceutical distribution division of UDG Healthcare
McKesson Corp. (MCK) CEO, President and Chairman John Hammergren (Insider Trades) sold 101,835 shares of the company on Oct. 12. The average price per share was $190.51. McKesson is a healthcare service and information technology company dedicated to making the business of healthcare run well. The company has a market cap of $44.11 billion and a P/S ratio of 0.24. Read more...
Weekly Insider Sells Highlight: MCK, FEYE, GOOG, CI
According to GuruFocus Insider Data, the largest insider sells during the past week were: McKesson Corp, FireEye Inc, Google Inc, and Cigna Corp. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 20.15
MCK's P/E(ttm) is ranked higher than
65% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.00 vs. MCK: 20.15 )
Ranked among companies with meaningful P/E(ttm) only.
MCK' s P/E(ttm) Range Over the Past 10 Years
Min: 8.15  Med: 18.60 Max: 38.36
Current: 20.15
8.15
38.36
Forward P/E 12.24
MCK's Forward P/E is ranked higher than
75% of the 12 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.87 vs. MCK: 12.24 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 17.64
MCK's PE(NRI) is ranked higher than
75% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.00 vs. MCK: 17.64 )
Ranked among companies with meaningful PE(NRI) only.
MCK' s PE(NRI) Range Over the Past 10 Years
Min: 8.17  Med: 18.24 Max: 33.78
Current: 17.64
8.17
33.78
Price/Owner Earnings (ttm) 32.46
MCK's Price/Owner Earnings (ttm) is ranked lower than
68% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.85 vs. MCK: 32.46 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
MCK' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 5.5  Med: 12.23 Max: 38.44
Current: 32.46
5.5
38.44
P/B 4.35
MCK's P/B is ranked lower than
80% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.19 vs. MCK: 4.35 )
Ranked among companies with meaningful P/B only.
MCK' s P/B Range Over the Past 10 Years
Min: 1.31  Med: 2.73 Max: 6.98
Current: 4.35
1.31
6.98
P/S 0.21
MCK's P/S is ranked higher than
86% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.10 vs. MCK: 0.21 )
Ranked among companies with meaningful P/S only.
MCK' s P/S Range Over the Past 10 Years
Min: 0.08  Med: 0.18 Max: 0.32
Current: 0.21
0.08
0.32
PFCF 21.11
MCK's PFCF is ranked lower than
63% of the 19 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.63 vs. MCK: 21.11 )
Ranked among companies with meaningful PFCF only.
MCK' s PFCF Range Over the Past 10 Years
Min: 4.68  Med: 12.43 Max: 43.64
Current: 21.11
4.68
43.64
POCF 16.23
MCK's POCF is ranked higher than
52% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.16 vs. MCK: 16.23 )
Ranked among companies with meaningful POCF only.
MCK' s POCF Range Over the Past 10 Years
Min: 4.23  Med: 10.41 Max: 98.78
Current: 16.23
4.23
98.78
EV-to-EBIT 12.37
MCK's EV-to-EBIT is ranked higher than
68% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.35 vs. MCK: 12.37 )
Ranked among companies with meaningful EV-to-EBIT only.
MCK' s EV-to-EBIT Range Over the Past 10 Years
Min: -864.9  Med: 11.20 Max: 22.1
Current: 12.37
-864.9
22.1
EV-to-EBITDA 9.84
MCK's EV-to-EBITDA is ranked higher than
77% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.91 vs. MCK: 9.84 )
Ranked among companies with meaningful EV-to-EBITDA only.
MCK' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.5  Med: 9.30 Max: 116.5
Current: 9.84
4.5
116.5
PEG 1.11
MCK's PEG is ranked higher than
76% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.11 vs. MCK: 1.11 )
Ranked among companies with meaningful PEG only.
MCK' s PEG Range Over the Past 10 Years
Min: 0.16  Med: 1.23 Max: 8.81
Current: 1.11
0.16
8.81
Shiller P/E 32.11
MCK's Shiller P/E is ranked lower than
59% of the 17 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.60 vs. MCK: 32.11 )
Ranked among companies with meaningful Shiller P/E only.
MCK' s Shiller P/E Range Over the Past 10 Years
Min: 14.91  Med: 30.26 Max: 51.52
Current: 32.11
14.91
51.52
Current Ratio 1.11
MCK's Current Ratio is ranked lower than
84% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.64 vs. MCK: 1.11 )
Ranked among companies with meaningful Current Ratio only.
MCK' s Current Ratio Range Over the Past 10 Years
Min: 1.08  Med: 1.27 Max: 1.71
Current: 1.11
1.08
1.71
Quick Ratio 0.63
MCK's Quick Ratio is ranked lower than
86% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.12 vs. MCK: 0.63 )
Ranked among companies with meaningful Quick Ratio only.
MCK' s Quick Ratio Range Over the Past 10 Years
Min: 0.52  Med: 0.65 Max: 0.88
Current: 0.63
0.52
0.88
Days Inventory 31.48
MCK's Days Inventory is ranked higher than
73% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 49.82 vs. MCK: 31.48 )
Ranked among companies with meaningful Days Inventory only.
MCK' s Days Inventory Range Over the Past 10 Years
Min: 29.7  Med: 31.95 Max: 32.98
Current: 31.48
29.7
32.98
Days Sales Outstanding 33.58
MCK's Days Sales Outstanding is ranked higher than
79% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 57.83 vs. MCK: 33.58 )
Ranked among companies with meaningful Days Sales Outstanding only.
MCK' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.03  Med: 26.10 Max: 32.33
Current: 33.58
22.03
32.33
Days Payable 55.17
MCK's Days Payable is ranked lower than
59% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 62.84 vs. MCK: 55.17 )
Ranked among companies with meaningful Days Payable only.
MCK' s Days Payable Range Over the Past 10 Years
Min: 44.11  Med: 50.63 Max: 59.76
Current: 55.17
44.11
59.76

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.64
MCK's Dividend Yield is ranked lower than
89% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.91 vs. MCK: 0.64 )
Ranked among companies with meaningful Dividend Yield only.
MCK' s Dividend Yield Range Over the Past 10 Years
Min: 0.35  Med: 0.59 Max: 1.42
Current: 0.64
0.35
1.42
Dividend Payout 0.11
MCK's Dividend Payout is ranked higher than
97% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.33 vs. MCK: 0.11 )
Ranked among companies with meaningful Dividend Payout only.
MCK' s Dividend Payout Range Over the Past 10 Years
Min: 0.04  Med: 0.13 Max: 2
Current: 0.11
0.04
2
Dividend Growth (3y) 6.30
MCK's Dividend Growth (3y) is ranked lower than
67% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.50 vs. MCK: 6.30 )
Ranked among companies with meaningful Dividend Growth (3y) only.
MCK' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -21.7  Med: 0.00 Max: 44.2
Current: 6.3
-21.7
44.2
Forward Dividend Yield 0.67
MCK's Forward Dividend Yield is ranked lower than
85% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.97 vs. MCK: 0.67 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 1.17
MCK's Yield on cost (5-Year) is ranked lower than
83% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.70 vs. MCK: 1.17 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
MCK' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.64  Med: 1.08 Max: 2.59
Current: 1.17
0.64
2.59
3-Year Average Share Buyback Ratio 2.20
MCK's 3-Year Average Share Buyback Ratio is ranked higher than
87% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.80 vs. MCK: 2.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MCK' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -43.4  Med: -0.50 Max: 4.3
Current: 2.2
-43.4
4.3

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.03
MCK's Price/Projected FCF is ranked higher than
77% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.36 vs. MCK: 1.03 )
Ranked among companies with meaningful Price/Projected FCF only.
MCK' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.55  Med: 1.12 Max: 17.04
Current: 1.03
0.55
17.04
Price/DCF (Earnings Based) 1.65
MCK's Price/DCF (Earnings Based) is ranked higher than
57% of the 7 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.64 vs. MCK: 1.65 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.16
MCK's Price/Median PS Value is ranked lower than
58% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.03 vs. MCK: 1.16 )
Ranked among companies with meaningful Price/Median PS Value only.
MCK' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.51  Med: 1.02 Max: 3.62
Current: 1.16
0.51
3.62
Price/Peter Lynch Fair Value 1.01
MCK's Price/Peter Lynch Fair Value is ranked higher than
80% of the 15 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.30 vs. MCK: 1.01 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MCK' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.34  Med: 1.19 Max: 72.67
Current: 1.01
0.34
72.67
Earnings Yield (Greenblatt) (%) 8.07
MCK's Earnings Yield (Greenblatt) (%) is ranked higher than
72% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. MCK: 8.07 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MCK' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.5  Med: 8.80 Max: 17.6
Current: 8.07
4.5
17.6
Forward Rate of Return (Yacktman) (%) 22.82
MCK's Forward Rate of Return (Yacktman) (%) is ranked higher than
77% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.84 vs. MCK: 22.82 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MCK' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -21.2  Med: 20.20 Max: 94.3
Current: 22.82
-21.2
94.3

More Statistics

Revenue(Mil) $189131
EPS $ 8.37
Beta1.02
Short Percentage of Float1.15%
52-Week Range $148.29 - 243.61
Shares Outstanding(Mil)228.59

Analyst Estimate

Mar16 Mar17 Mar18
Revenue(Mil) 190,142 198,583 203,013
EPS($) 12.69 13.71 15.00
EPS without NRI($) 12.69 13.71 15.00

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:NYSE:CAH, NYSE:ABC, NAS:HSIC, HKSE:01099, SHSE:601607 » details
Traded in other countries:MCK.Germany, MCK.Mexico,
McKesson Corporation is a Delaware Corporation. The Company delivers pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs. The Company operates in two segments. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs and equipment and health and beauty care products throughout North America and internationally. This segment provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. This segment also provides medical-surgical supply distribution, equipment, logistics and other services to healthcare providers through a network of distribution centers within the U.S. In addition, this segment sells financial, operational and clinical solutions for pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing and other services. The McKesson Technology Solutions segment includes McKesson Health Solutions, which includes its InterQual clinical criteria solution, claims payment solutions and network performance tools. This segment also delivers enterprise-wide clinical, patient care, financial, supply chain, strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations. This segment's customers include hospitals, physicians, homecare providers, retail pharmacies and payers from North America. McKesson Distribution Solutions consists of the following businesses: North America pharmaceutical distribution and services, International pharmaceutical distribution and services and Medical Surgical distribution and services. The Company competes with other software services firms, consulting firms, shared service vendors, certain hospitals and hospital groups, payers, care management organizations, hardware vendors and internet-based companies with technology applicable to the healthcare industry.
» More Articles for MCK

Headlines

Articles On GuruFocus.com
Wallace Weitz Comments on McKesson Apr 22 2016 
Early Oil Investor Arnold Van Den Berg Keeps Buying Energy Stocks in Q1 Apr 19 2016 
Stocks Trading Below Peter Lynch Earnings Line Mar 01 2016 
A Short-Term Problem Creates Long-Term Opportunity in Lannett Company Jan 12 2016 
Larry Robbins Buys Cigna, Monsanto and Sells Out McDonald's Dec 09 2015 
A Look at Recent Insider Trades Oct 16 2015 
McKesson Officer Sells 101,835 Shares of Company Oct 15 2015 
The Case for Investing in AmerisourceBergen Aug 13 2015 
Weekly Insider Sells Highlight: MCK, FEYE, GOOG, CI Jul 21 2015 
Litespeed Management adds to its stake in MedAssets Jul 07 2015 

More From Other Websites
McKesson (MCK) Q4 Earnings: Stock Likely To Disappoint May 02 2016
It Looks Like McKesson Is Forming a Bottom Apr 28 2016
McKesson downgraded by Standpoint Research Apr 26 2016
McKesson Joins Blue Cross Blue Shield of Arizona to Form National Value-based Services Organization Apr 25 2016
Black Lives Matter gave him fame, but Baltimore isn't biting Apr 24 2016
McKesson Corporation to Present at the Bank of America Merrill Lynch 2016 Health Care Conference Apr 20 2016
McKesson Corporation Fiscal 2016 Fourth Quarter Conference Call Scheduled for May 4, 2016 Apr 13 2016
Five Healthcare Stocks that Disappointed Hedge Funds Apr 12 2016
McKesson Completes the Acquisitions of Vantage Oncology and Biologics Apr 04 2016
McCormick Turns Up the Heat on Premier Foods Mar 30 2016
McCormick raises bid proposal for Premier Foods Mar 30 2016
McCormick raises possible offer for Premier Foods Mar 30 2016
McKesson (MCK) to Restructure Operations, Lower Headcount Mar 21 2016
McKesson Restructures Amid Walgreens, CVS Health Deals Mar 18 2016
What do McKesson's 1,600 layoffs mean? Mar 18 2016
[$$] McKesson Details Savings From Expected Layoffs Mar 18 2016
McKesson to cut jobs, take charge as part of restructuring plan Mar 18 2016
MCKESSON CORP Files SEC form 8-K, Costs Associated with Exit or Disposal Activities Mar 18 2016
Drug wholesaler McKesson to cut 1,600 jobs in U.S. Mar 17 2016
[$$] McKesson to Cut Roughly 4% of Its U.S. Workforce Mar 17 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK